Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Twitter-enabled Mobile Messaging for Smoking Relapse Prevention

NCT01602536 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT01602536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01602536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Twitter-enabled Mobile Messaging for Smoking Relapse Prevention
Lead sponsor
University of California, Irvine
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2014
Enrollment
160 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

smoking